Klebsiella Pneumoniae Infection Clinical Trial
Official title:
WGS-guided Tracking and Infection Control Measures of Carbapenem-resistant Klebsiella Pneumoniae
Verified date | May 2020 |
Source | Huashan Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to investigate the effect of the infection control measures based on the active screening of carbapenem-resistant Klebsiella pneumoniae and whole-genome based tracking and surveillance though the hospital.
Status | Recruiting |
Enrollment | 1000 |
Est. completion date | September 30, 2021 |
Est. primary completion date | September 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: 1. The patient was admitted to the ICU of neurosurgery in the west hospital of huashan hospital affiliated to fudan university from September 2019 to September 2021, or transferred from the ICU of another hospital 2. The patient is more than 18 years old and less than 80 years old, regardless of gender. 3. Informed consent of the patient; Exclusion Criteria: 1. Patients participating in other clinical trials at the same time 2. Pregnant 4. People who will affect the outcome of the study: whose specimens could not be received or not enough for testing |
Country | Name | City | State |
---|---|---|---|
China | Infectious department of Huashan Hospital, Fudan University | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Huashan Hospital | Sumitomo Pharmaceuticals (Suzhou) Co. Ltd |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate the influence of WGS-based screen and control measures on the CRKP occurrence rate | 2 years | ||
Secondary | Analysis of transmission pattern and route pre and post WGS-based tracking | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03598543 -
Epidemiology of Klebsiella Pneumoniae in China
|
||
Completed |
NCT04959344 -
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03245632 -
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
|
N/A | |
Recruiting |
NCT03891433 -
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
|
Phase 4 |